Provided by Tiger Fintech (Singapore) Pte. Ltd.

Imago BioSciences, Inc.

36.01
0.0000
Volume:- -
Turnover:5.02M
Market Cap:1.22B
PE:-19.70
High:36.01
Open:36.01
Low:36.01
Close:36.01
Loading ...

Company Profile

Company Name:
Imago BioSciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.